(Nasdaq: AGEN) today
published a new blog post on The Chairman's Blog, written by the
company's Chairman and CEO, Garo Armen. TheChairmansBlog.com is an
exclusive online media publication that enables key executive
officers a unique platform to share insights about their company and
Chairman and CEO, Garo Armen, published an inaugural blog post in
which he writes about the evolution of immunotherapy and its effect
on the company. He also highlights upcoming key milestone events as
they relate to Ageuns' pipeline. Read the full blog post on
Agenus Inc. is a biotechnology company
working to develop treatments for cancers and infectious diseases.
The company is focused on immunotherapeutic products based on strong
platform technologies with multiple product candidates advancing
through the clinic, including several product candidates that have
advanced into late-stage clinical trials through corporate partners.
For more information, please visit http://www.agenusbio.com/.
an exclusive, online media publication where publically and
privatively held firms alike share insights about their companies and
industries. TheChairmansBlog.com enables upper tier management to
discuss issues that are of importance to their stakeholders,
shareholders, and interested parties in an informal environment. In
addition to management's insightful blog posts, TheChairmansBlog.com
staff and aggregate partners contribute articles on finance,
technology, health, and energy while providing updated market trends,
news, and information.
Leave a comment...